201 results
Page 3 of 11
8-K
EX-10.17
51gjzkgaswow74uj
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.6
cwe5gp4 1fs13mmbwu
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.5
s3v0guxxizpfkz ti
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
425
uiv10yziicq3w
6 Dec 22
Business combination disclosure
4:04pm
8-K
EX-99.1
snxe 68bvou
6 Dec 22
Regulation FD Disclosure
4:02pm
425
w457x
15 Nov 22
Business combination disclosure
4:03pm
8-K
EX-99.1
0bvetm orj
15 Nov 22
Kineta Announces FDA Acceptance of Investigational New Drug (IND) Application for KVA12123 for the Treatment of Advanced Solid Tumors
4:02pm
424B3
j3m uoe3acfmmcte0d
10 Nov 22
Prospectus supplement
4:21pm
425
acroov95
26 Oct 22
Business combination disclosure
5:17pm
8-K
EX-99.1
na2nmuf5kzwu44jji4k
26 Oct 22
Regulation FD Disclosure
5:14pm
425
1ar a5rptoept0
26 Oct 22
Business combination disclosure
5:10pm
8-K
EX-99.1
ir4eu
26 Oct 22
Regulation FD Disclosure
5:08pm
425
4bq7 0vm6tt
17 Oct 22
Business combination disclosure
4:03pm
8-K
jp5ntqwllg5a tf5l
17 Oct 22
Clinical trial anticipated to begin in late 2022
4:02pm
8-K
EX-99.1
znk9ylgo8qb
17 Oct 22
Clinical trial anticipated to begin in late 2022
4:02pm